SFRP4 and breast cancer: Interestingly, both DKK-1 and sFRP4 are antagonists of the Wnt signaling pathway, but the effect of CBX7 in regulating sFRP4 in colon cancer is quite different from the effect of regulating DKK-1 in breast cancer.